Dow launches flake PEG at CPhI
14-Oct-2009 - Dow Polyglycols and Surfactants is using CPhI 2009 in Madrid to launch Carbowax Sentry PEG...
USP targets counterfeits in Cambodia
12-Oct-2009 - The USAID and USP have launched a campaign to tackle counterfeits in Cambodia and Greater...
CPhI 2009 show preview
08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and...
Labopharm upbeat about depression drug after FDA OKs API maker
08-Oct-2009 - Canadian drugmaker Labopharm says its Italian API maker Gruppo Angelini has resolved all the US...
Less potent heparin begins shipping on Thursday, says FDA
05-Oct-2009 - From Thursday onwards all formulations of the blood thinner heparin shipped in the US will...
News in brief
India’s formulation market worth $14bn by 2013, says Angel Broking
05-Oct-2009 - India’s drug formulation market will grow 12 per cent a year and be worth $13.7bn...
Ash Stevens starts $6m expansion
01-Oct-2009 - Buoyed by an increase in repeat business and deals with large pharma companies Ash Stevens...
BASF unveils Asia growth plan
01-Oct-2009 - German chemicals giant BASF wants to double the revenue it generates in the Asia-Pacific, with...
Hovione's Loures plant gets latest FDA pre-approval nod
30-Sep-2009 - Portuguese API maker Hovione says its contract manufacturing plant in Loures has passed a pre-approval...
Patheon adds development services at Italian plant
30-Sep-2009 - Canadian CMO Patheon has set up a pharmaceutical development services (PDS) sterile products suite at...
News in brief
BioVectra wins contract to make Prolanta for trials
29-Sep-2009 - Canadian biologics CMO BioVectra has been contracted to make trial supplies of the candidate cancer...
Nycomed plans €75m Russian plant; may up €4.5bn bid for Solvay
28-Sep-2009 - Late last week Swiss drugmaker Solvay confirmed its plan to invest up to $75m (€51m)...
News in brief
Camlin Fine Chemicals mulls API unit sale
28-Sep-2009 - The pharmaceutical division of Indian API maker Camlin Fine chemicals may be put up for...
News in brief
Richter-Helm adds capacity at biologics plant
28-Sep-2009 - Contract manufacturer Richter-Helm BioLogics has completed the modernisation of its GMP standard biologics facility in...
Aesica cleared to make controlled APIs at Cramlington
25-Sep-2009 - UK based contract API maker Aesica Pharmaceuticals has been granted a Home Office license to...
News in brief
GSK extends Catalent softgel contract
25-Sep-2009 - US CMO Catalent has had its Lovaza softgel manufacturing contract with UK drug major GSK...
Ampac bulks up API capacity with 3 LLC units
24-Sep-2009 - Ampac Fine Chemicals (AFC) has added three new commercial-scale Hastelloy liquid-liquid centrifuges to its API...
Teva further streamlines ops with Czech plant closure
23-Sep-2009 - Israeli generics giant Teva Pharmaceutical Industries will close one of its manufacturing plants in the...
News in brief
Novasep’s HPAPI plant gets SafeBridge certification
18-Sep-2009 - Novasep’s API manufacturing facility in Le Mans, France has been certified under the potent compound...
Welcome, here’s a warning letter; Dekkers named as Bayer CEO
16-Sep-2009 - News of Bayer’s selection of ex-Thermo Fisher Scientific boss Marijn Dekkers as its CEO was...
Slump bad for North American APIs, but biotech to lead recovery
07-Sep-2009 - The global economic crisis has drastically reduced the growth of the North America API market,...
News in brief
BASF hikes carboxylic acid prices in Europe
31-Aug-2009 - German chemicals manufacturer BASF has raised the price of two of its range of carboxylic...
Durect and King sign long-term Remoxy excipient supply deal
31-Aug-2009 - Chemicals firm Durect will supply drugmaker King Pharmaceuticals with two excipients used in the manufacture...
Roche buys Lonza’s Singapore biologics plant
31-Aug-2009 - Basel-headquartered Roche has paid fellow Swiss firm Lonza $290m (€203m) for its Singapore biologics plant...
Silence collaborating on AtuRNAi drug delivery tech
27-Aug-2009 - Dainippon Sumitomo Pharma has entered into a collaboration to develop Silence Therapeutics’ AtuRNAi delivery technology...
